Neuro-Oncology Reviews
Volume
26 Number 12
30 June 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 12, 30 June
Cohen
KJ, et al., PDQ Pediatric Treatment Editorial Board.
Childhood
Astrocytomas, Other Gliomas, and Glioneuronal/Neuronal Tumors
Treatment (PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ.
2024
Jun
17. NCBI
Bookshelf ID:
NBK65944.
PMID:
26389382.
Review. ˍ
Pollack IF, Felker J, Frederico SC, Raphael I, Kohanbash G.
Immunotherapy for pediatric low-grade
gliomas.
Childs
Nerv Syst. 2024 Jun 17. doi:
10.1007/s00381-024-06491-9. PMID:
38884777. Review; Book chapter˰
ˍ
Wu
H, Cheng Y, Gao W, Chen P, Wei Y, Zhao H, Wang F.
Progress
in the application of ultrasound in glioma surgery.
Front
Med (Lausanne).
2024 Jun 17;11:1388728. doi:
10.3389/fmed.2024.1388728. PMID:
38957299. Review. ˍ
Gue
R, Lakhani DA.
The
2021 World Health Organization Central Nervous System Tumor
Classification: The Spectrum of Diffuse Gliomas.
Biomedicines.
2024 Jun 18;12(6):1349. doi:
10.3390/biomedicines12061349. PMID:
38927556.
Review. ˍ
Keshavarz
M, Dianat-Moghadam H, Ghorbanhosseini SS, Sarshari B.
Oncolytic
virotherapy improves immunotherapies targeting cancer stemness in
glioblastoma.
Biochim
Biophys Acta Gen Subj.
2024 Jun 18;1868(9):130662. doi:
10.1016/j.bbagen.2024.130662. PMID:
38901497. Review˰
ˍ
Liang T, Gu L, Kang X, Li J, Song Y, Wang Y, Ma W.
Programmed
cell death disrupts inflammatory tumor microenvironment (TME) and
promotes glioblastoma evolution.
Cell
Commun Signal. 2024 Jun 18;22(1):333. doi:
10.1186/s12964-024-01602-0. PMID:
38890642.
Review. ˍ
Slika H, Shahani A, Wahi R, Miller J, Groves M, Tyler B.
Overcoming Treatment Resistance in
Medulloblastoma: Underlying Mechanisms and Potential Strategies.
Cancers
(Basel). 2024 Jun 18;16(12):2249. doi:
10.3390/cancers16122249. PMID:
38927954.
Review. ˍ
Chang
C, Chavarro VS, Gerstl JVE, Blitz SE, Spanehl L, Dubinski D,
Valdes PA, Tran LN, Gupta S, Esposito L, Mazzetti D, Gessler FA,
Arnaout O, Smith TR, Friedman GK, Peruzzi P, Bernstock JD.
Recurrent
Glioblastoma-Molecular Underpinnings and Evolving Treatment
Paradigms.
Int
J Mol Sci.
2024 Jun 19;25(12):6733. doi:
10.3390/ijms25126733. PMID:
38928445.
Review. ˍ
Stergiopoulos GM, Concilio SC, Galanis E.
An
Update on the Clinical Status, Challenges, and Future Directions
of Oncolytic Virotherapy for Malignant Gliomas.
Curr
Treat Options Oncol. 2024 Jun 19. doi:
10.1007/s11864-024-01211-6. PMID:
38896326. Review˰
ˍ
Mohammadi
S, Ghaderi S, Jouzdani AF, Azinkhah I, Alibabaei S, Azami M,
Omrani V.
Differentiation
Between High-Grade Glioma and Brain Metastasis Using Cerebral
Perfusion-Related Parameters (Cerebral Blood Volume and Cerebral
Blood Flow): A Systematic Review and Meta-Analysis of
Perfusion-weighted MRI Techniques.
J
Magn Reson Imaging.
2024 Jun 20. doi:
10.1002/jmri.29473. PMID:
38899965. Review; Meta-Analysis˰ ˍ
Nguyen
TTT, Greene LA, Mnatsakanyan H, Badr CE.
Revolutionizing
Brain Tumor Care: Emerging Technologies and Strategies.
Biomedicines.
2024 Jun 20;12(6):1376. doi:
10.3390/biomedicines12061376. PMID:
38927583. Review.
ˍ
Veiga
VC, Peres SV, Ostolin TLVDP, Moraes FR, Belucci TR, Clara CA,
Cavalcanti AB, Chaddad-Neto FEA, Batistella GNR, Neville IS, Baeta
AM, Yamada CAF; TROMBOGLIO Study Group.
Incidence
of venous thromboembolism and bleeding in patients with malignant
central nervous system neoplasm: Systematic review and
meta-analysis.
PLoS
One.
2024 Jun 20;19(6):e0304682. doi:
10.1371/journal.pone.0304682. PMID:
38900739. Review; Meta-Analysis.
ˍ
Weller J, Potthoff AL, Zeyen T, Schaub C, Duffy C, Schneider M,
Herrlinger U.
Current status of
precision oncology in adult glioblastoma.
Mol
Oncol. 2024 Jun 20. doi:
10.1002/1878-0261.13678. PMID:
38899374. Review.
ˍ
Bernstock JD, Gerstl JVE, Chen JA, Johnston BR, Nonnenbroich LF,
Spanehl L, Gessler FA, Valdes PA, Lu Y, Srinivasan SS, Smith TR,
Peruzzi P, Rolston JD, Stone S, Chiocca EA.
The
Case for Neurosurgical Intervention in Cancer Neuroscience.
Neurosurgery.
2024 Jun 21. doi:
10.1227/neu.0000000000003039. PMID:
38904388. Review˰
ˍ
Lu VM, Jallo GI, Shimony N.
Intramedullary
pediatric low-grade glioma of the spine.
Childs
Nerv Syst. 2024 Jun 21. doi:
10.1007/s00381-024-06499-1. PMID:
38904769. Review˰
ˍ
Śledzińska-Bebyn P,
Furtak J, Bebyn M, Serafin Z.
Beyond
conventional imaging: Advancements in MRI for glioma malignancy
prediction and molecular profiling.
Magn
Reson Imaging.
2024 Jun 22;112:63-81. doi:
10.1016/j.mri.2024.06.004. PMID:
38914147. Review˰
ˍ
Xu H, Zhao X, Luo J.
Combination
of tumor antigen drainage and immune activation to promote a
cancer-immunity cycle against glioblastoma.
Cell
Mol Life Sci.
2024 Jun 22;81(1):275. doi:
10.1007/s00018-024-05300-5. PMID:
38907858. Review.
ˍ
Limaye
W, Ahmad T.
Advanced
MRI imaging techniques in pediatric brain tumors.
Pediatr
Radiol.
2024 Jun 24. doi:
10.1007/s00247-024-05966-w. PMID:
38913187. Review˰
ˍ
van
den Bent MJ, French PJ, Brat D, Tonn JC, Touat M, Ellingson BM,
Young RJ, Pallud J, von Deimling A, Sahm F, Figarella Branger D,
Huang RY, Weller M, Mellinghoff IK, Cloughsey TF, Huse JT, Aldape
K, Reifenberger G, Youssef G, Karschnia P, Noushmehr H, Peters KB,
Ducray F, Preusser M, Wen PY.
The
biological significance of tumor grade, age, enhancement and
extent of resection in IDH mutant gliomas: how should they inform
treatment decision in the era of IDH inhibitors? Invited review.
Neuro
Oncol.
2024 Jun 24:noae107. doi:
10.1093/neuonc/noae107. PMID:
38912846. Review.
ˍ
Dixon
S, O'connor AT, Brooks-Noreiga C, Clark MA, Levy A, Castejon AM.
Role
of renin angiotensin system inhibitors and metformin in
Glioblastoma Therapy: a review.
Cancer
Chemother Pharmacol.
2024 Jun 25. doi:
10.1007/s00280-024-04686-0. PMID:
38914751. Review˰
ˍ
Berner
AM, Atkinson SE.
The
implications of hormone treatment for cancer risk, screening and
treatment in transgender individuals.
Best
Pract Res Clin Endocrinol Metab.
2024 Jun 26:101909. doi:
10.1016/j.beem.2024.101909. PMID:
38964988. Review. ˍ
Biswas A, Rao HR, Wagner MW.
Pediatric-type
diffuse low-grade gliomas.
Childs
Nerv Syst. 2024
Jun 26. doi:
10.1007/s00381-024-06500-x. PMID:
38926169. Review˰
ˍ
Feldman L.
Hypoxia within the
glioblastoma tumor microenvironment: a master saboteur of novel
treatments.
Front
Immunol. 2024 Jun 26;15:1384249. doi:
10.3389/fimmu.2024.1384249. PMID:
38994360. Review. ˍ
Fouda
MA, Kallman S, Boorstin R, Sacks-Zimmerman A, Pannullo SC, Bender
HA.
The
unseen impact - a deep dive into neurocognitive impairment among
patients with intracranial meningiomas: a comprehensive systematic
review of the literature.
Neurosurg
Rev.
2024 Jun 26;47(1):294. doi:
10.1007/s10143-024-02530-w. PMID:
38922363. Review˰
ˍ
Kumawat C, Takahashi T, Date I, Tomita Y, Tanaka M, Arataki S,
Komatsubara T, Flores AOP, Yu D, Jain M.
State-of-the-Art
and New Treatment Approaches for Spinal Cord Tumors.
Cancers
(Basel). 2024 Jun 27;16(13):2360. doi:
10.3390/cancers16132360. PMID:
39001422. Review. ˍ
Bukhari SS, Ahmed N, Shamim MS.
Super
selective intra-arterial cerebral infusion (SSIACI) for newly
diagnosed and recurrent glioblastoma.
J
Pak Med Assoc. 2024 Jun 28;74(7):1380-1381. doi:
10.47391/JPMA.24-55. PMID:
39028079. Review. ˍ
Ellingson
BM, Sanvito F, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Pope
WB, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL,
Weller M, Galanis E, Groot J, Gilbert MR, Lassman AB, Shiroishi
MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Vogelbaum
MA, van den Bent M, Chang SM, Wen PY.
A
Neuroradiologist's Guide to Operationalizing the Response
Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for
Gliomas in Adults.
AJNR
Am J Neuroradiol.
2024 Jun 28:ajnr.A8396. doi:
10.3174/ajnr.A8396. PMID:
38926092. Guidelines˰ ˍ
Knabbe J, Kowalski T, Seliger C.
Pharmacological
treatment of depression in patients with brain tumors.
Int
J Cancer. 2024
Jun 28. doi:
10.1002/ijc.35058. PMID:
38943227. Review˰
ˍ
Nonnenbroich LF, Bouchal SM, Millesi E, Rechberger JS, Khatua S,
Daniels DJ.
H3K27-Altered Diffuse
Midline Glioma of the Brainstem: From Molecular Mechanisms to
Targeted Interventions.
Cells.
2024 Jun 28;13(13):1122. doi:
10.3390/cells13131122. PMID:
38994974. Review. ˍ
Silva-Hurtado TJ, Inocencio JF, Yong RL.
Emerging
applications of hypomethylating agents in the treatment of
glioblastoma (Review).
Mol
Clin Oncol. 2024 Jun 28;21(3):59. doi:
10.3892/mco.2024.2757. PMID:
39006906. Review. ˍ
Agosti E, Garaba A, Antonietti S, Ius T, Fontanella MM, Zeppieri
M, Panciani PP.
CAR-T Cells Therapy in
Glioblastoma: A Systematic Review on Molecular Targets and
Treatment Strategies.
Int
J Mol Sci. 2024 Jun 29;25(13):7174. doi:
10.3390/ijms25137174. PMID:
39000281. Review. ˍ
*Kinslow CJ, Roy S, Iwamoto FM, Brown PD, DeStephano DM, Canoll
PD, Qureshi SS, Gallito M, Sisti MB, Bruce JN, Horowitz DP,
Kachnic LA, Neugut AI, Yu JB, Mehta MP, Cheng SK, Wang TJC.
The
IDH paradox: Meta-analysis of alkylating chemotherapy in
IDH-wildtype and -mutant lower grade gliomas.
Neuro
Oncol. 2024 Jun 29:noae102. doi:
10.1093/neuonc/noae102. PMID:
38943513. Meta-analysis˰
ˍ
Yang Z, Wu H, Wang Z, Bian E, Zhao
B.
The
role and application of small extracellular vesicles in glioma.
Cancer
Cell Int. 2024
Jun 29;24(1):229. doi:
10.1186/s12935-024-03389-z. PMID:
38951882.
Review. ˍ